Rapamycin inhibits vascular smooth muscle cell migration.
Abnormal vascular smooth muscle cell (SMC) proliferation and migration contribute to the development of restenosis after percutaneous transluminal coronary angioplasty and accelerated arteriopathy after cardiac transplantation. Previously, we reported that the macrolide antibiotic rapamycin, but not...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Principais autores: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
1996
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC507677/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8941644/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI119038 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|